Today: 4 May 2026

AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

Nvidia traded flat after reports of advanced talks to buy Israel’s AI21 Labs for up to $3 billion. Meta gained 1.17% to $666.40 after announcing plans to acquire AI startup Manus, with the deal valued at $2 billion to $3 billion by a source. Broader tech stocks were mixed in light, year-end trading. Investors awaited Federal Reserve meeting minutes for signals on 2026 interest rates.
Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

Bitcoin rose 0.8% to $88,320 in New York Tuesday afternoon. U.S. spot bitcoin ETFs saw $19.3 million in net outflows Monday, led by BlackRock’s IBIT. Coinbase shares edged up 0.2%, while Strategy gained 1.4% after disclosing a $108.8 million bitcoin purchase. Fed minutes are due at 2 p.m. ET.
Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics shares fell 3.3% to $35.61 by early afternoon Tuesday, underperforming biotech peers as investors awaited updates on its blood-pressure drug lorundrostat. The stock remains up 183% over 52 weeks but is down 25% from its November high. Mineralys plans to file for FDA approval of lorundrostat by early 2026 and expects Phase 2 results in the first quarter of that year.
Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals shares dropped 4.2% to $107.85 in early afternoon trading Tuesday as biotech stocks broadly declined. Investors are awaiting an FDA decision on expanding Imcivree’s label, now expected by March 20, 2026. Board member Camille L. Bedrosian resigned effective immediately, according to an SEC filing. Major biotech ETFs fell over 1% while the broader market was flat.
S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

Meta rose 1.2% after announcing plans to acquire AI startup Manus, reportedly valued at $2–3 billion. The Dow slipped 0.24%, S&P 500 fell 0.09%, and Nasdaq eased 0.07% in midday trading as investors awaited Federal Reserve meeting minutes. Apple and Nvidia edged lower, while Microsoft ticked up. T1 Energy climbed 3.7% after selling $160 million in clean-energy tax credits.
Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Warby Parker shares fell 3.9% to $22.11 in early afternoon trading Tuesday, underperforming the broader market amid thin year-end volumes. Nearly 3 million shares changed hands as investors awaited Federal Reserve meeting minutes. The company’s recent AI glasses partnership with Google has drawn attention, but traders remain focused on near-term fundamentals. Retail stocks were mixed, with National Vision down 1.7%.
30 December 2025
Dow Jones today: DJIA slips in thin year-end trade as Fed minutes loom

Dow Jones today: DJIA slips in thin year-end trade as Fed minutes loom

The Dow slipped 0.12% to 48,404.49 by early afternoon Tuesday, with financials and tech stocks weighing and communication services rising after Meta’s AI acquisition. Investors awaited Federal Reserve minutes due at 2 p.m. ET, following a recent rate cut that split policymakers. Treasury yields edged up, with the 10-year near 4.13%. The S&P 500 and Nasdaq were little changed in thin, year-end trading.
France vows stable electricity bills in 2026 — but new charges could still push costs up

France vows stable electricity bills in 2026 — but new charges could still push costs up

France will scrap its ARENH nuclear pricing scheme on Jan. 1, giving EDF more freedom to sell nuclear power. The government says regulated electricity tariffs should remain broadly stable in 2026 and 2027. A new mechanism will claw back excess EDF nuclear revenues above set thresholds, but officials say it is unlikely to trigger soon. Consumer group UFC-Que Choisir warns a separate policy could add about 50 euros to annual household energy bills.
30 December 2025
Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Corcept Therapeutics shares fell 8.9% to $72.72 in early afternoon trading Tuesday as investors awaited the FDA’s decision on relacorilant, due later in the day. SEC filings showed CEO Joseph Belanoff and Chief Business Officer Gary Charles Robb exercised stock options and withheld shares for taxes. About 897,000 shares changed hands. The drop outpaced declines in major biotech indexes.
Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Equinox Gold shares rose 2.2% to around $14.30 on Tuesday as gold prices rebounded, following a sharp drop the previous day. About 2.2 million shares traded, with the stock moving between $14.18 and $14.58. Investors are watching for Federal Reserve minutes later in the day for signals on 2026 rate cuts. No major company news since Equinox announced its Brazil asset sale on Dec. 14.
30 December 2025
Target stock slips today as activist pressure stays in focus — what investors are watching next

Target stock slips today as activist pressure stays in focus — what investors are watching next

Target shares fell 0.7% to $97.38 in midday trading Tuesday, underperforming a weaker retail sector. The move follows reports that hedge fund Toms Capital Investment Management has taken a significant, undisclosed stake as Target prepares for a CEO transition in February. Investors await filings that could reveal TCIM’s intentions. Target shares are down more than 28% in 2025.
30 December 2025
IREN stock slips today as year-end tech jitters hit AI data-center plays

IREN stock slips today as year-end tech jitters hit AI data-center plays

IREN shares dropped 1.4% to $38.87 by midday Tuesday, underperforming bitcoin, which rose 0.7%. The move follows IREN’s early-December share sale and $2.3 billion convertible note issue, fueling investor focus on funding and dilution. Trading volume reached about 10.7 million shares. Core Scientific fell 1.2%, while Marathon Digital was little changed.
30 December 2025

Stock Market Today

  • Marvell Technology's Stock Surges 165% in 1 Year but Faces Overvaluation Concerns
    May 3, 2026, 7:46 PM EDT. Marvell Technology's shares have surged 165.4% over the past year amid strong market interest in its semiconductor position supporting AI and data center growth. Despite this rally, valuation metrics raise caution. A Discounted Cash Flow (DCF) model estimates intrinsic value at around $64.35 per share, well below the recent price of $164.95, suggesting the stock is overpriced by over 150% on this basis. Its Price-to-Earnings (P/E) ratio and other traditional valuation tools also point to overvaluation risks. Investors are weighing Marvell's growth potential against these stretched valuations as broader market themes continue to drive interest in semiconductor firms tied to AI infrastructure and cloud demand.

Latest article

Navitas Semiconductor Stock Is Running Hot. Tuesday Will Test the AI Power Story

Navitas Semiconductor Stock Is Running Hot. Tuesday Will Test the AI Power Story

4 May 2026
Navitas Semiconductor shares rose 5.76% to $17.45 Friday on heavy volume ahead of first-quarter results due Tuesday. The company forecast Q1 revenue of $8.0–$8.5 million after posting a $41.4 million loss last quarter. Management highlighted new high-power chips for AI data centers but warned that design wins do not guarantee near-term sales. CEO Chris Allexandre and CFO Tonya Stevens will discuss results May 5.
Eaton Stock Faces May 5 Test as AI Data Center Bets Meet Earnings Reality

Eaton Stock Faces May 5 Test as AI Data Center Bets Meet Earnings Reality

4 May 2026
Eaton will report first-quarter results before the NYSE opens Tuesday, following its Boyd Thermal acquisition and push into AI data-center power systems. Shares closed Friday at $425.55, down 1.72%, with a market value near $166 billion. Wall Street expects adjusted earnings of $2.75 per share for the March quarter. Investors are watching for signs that AI data-center demand is driving orders and profit.
Blue Owl Capital Faces Fresh Private-Credit Test After Brown Slashes OBDC Stake

Blue Owl Capital Faces Fresh Private-Credit Test After Brown Slashes OBDC Stake

4 May 2026
Brown University cut its stake in Blue Owl Capital Corp’s main private-credit fund by 53%, holding 1.5 million OBDC shares at March 31, down from 3.2 million at the end of 2025. Blue Owl’s quarterly filing showed revenue rose to $753.8 million, net income doubled to $15.5 million, but its direct-lending strategy posted a 1.1% net loss as repayments outpaced new loans.
Go toTop